Nivolumab to be made available to lung cancer patients in England and Wales, says NICE NICE agrees to make immunotherapy drug nivolumab available to lung cancer patients in England and Wales.…
FDA approves first biosimilar for cancer The US Food and Drug Administration (FDA) has approved a biosimilar of Avastin (bevacizumab) for multiple cancer indications.…
Ixazomib (Ninlaro) combination rejected for multiple myeloma in second draft guidance The National Institute for Health and Care Excellence (NICE) has again rejected ixazomib (Ninlaro) in combination with lenalidomide and dexamethasone (IRd) for the treatment of patients with relapsed or refractory multiple myeloma who have received one or more previous therapies.…
Alectinib reduces CNS progression in NSCLC Data from two clinical trials have shown that second-generation ALK inhibitor alectinib (Alecensa, Roche) reduces central nervous system progression in ALK-positive non-small cell lung carcinoma.…
Keytruda approved in Europe to treat metastatic urothelial cancer Pembrolizumab — marketed as Keytruda — has been given approval for use across Europe for some patients with a specific kind of bladder cancer, following a decision by the European Commission.…
FDA approves AML drug 17 years after initial approval The Food and Drug Administration has approved the use of gemtuzumab (Mylotarg) for the treatment of adults with acute myeloid leukaemia whose tumours express the CD33 antigen.…
FDA approves cancer therapy using genetically engineered cells The US Food and Drug Administration has approved the first gene therapy, which will be available to children and adults with acute lymphoblastic leukaemia.…
Statins could protect against breast cancer Being diagnosed with hyperlipidaemia could protect you against breast cancer and early mortality, according to research presented at the European Society of Cardiology Congress 2017.…
Anti-inflammatory drug protects against further attacks in heart attack survivors Heart attack survivors who receive regular injections of the anti-inflammatory drug canakinumab have a reduced risk of further attacks and a significantly reduced risk of cancer, according to research published in The New England Journal of Medicine…
Study into colon cancer highlights usefulness of pig model The pig model can help in developing preventive strategies against gut bacterial dysbiosis and inflammation-promoted diseases, such as colon cancer, researchers find.…